Story perspectives

NYU Langone Health Ordered to Resume Transgender Treatments

3/3/2026

Summary

Story summary

The New York Attorney General's Office ordered NYU Langone Health to resume puberty-blocking medications and hormone treatments for transgender adolescents.
The order follows the hospital's suspension of the Transgender Youth Health Program amid federal threats to withdraw funding.
The attorney general's office warned of potential anti-discrimination violations and noted access for non-transgender pediatric patients.
It received complaints and ordered restoration of services for patients under 19 diagnosed with gender dysphoria.

1 of 1

Story summary

The New York Attorney General's Office ordered NYU Langone Health to resume puberty-blocking medications and hormone treatments for transgender adolescents.
The order follows the hospital's suspension of the Transgender Youth Health Program amid federal threats to withdraw funding.
The attorney general's office warned of potential anti-discrimination violations and noted access for non-transgender pediatric patients.
It received complaints and ordered restoration of services for patients under 19 diagnosed with gender dysphoria.